共 303 条
[1]
Di Chiro G(1982)Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1323-1329
[2]
DeLaPaz RL(1995)Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET Radiology 195 47-52
[3]
Brooks RA(1996)Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine Am J Neuroradiol 17 345-353
[4]
Sokoloff L(1998)Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 778-785
[5]
Kornblith PL(1998)11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1316-1322
[6]
Smith BH(2001)Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg 95 746-750
[7]
Patronas NJ(2005)Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma J Neurosurg 103 498-507
[8]
Kufta CV(2005)11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET Eur J Nucl Med Mol Imaging 32 52-59
[9]
Kessler RM(2016)Response assessment in neuro-oncology working group and European association for neuro-oncology recommendations for the clinical use of PET imaging in gliomas Neuro Oncol 18 1199-1208
[10]
Johnston GS(2006)[11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence Am J Neuroradiol 27 1432-1437